Treatment of cytomegalovirus retinitis with a sustained-release ganciclovir implant. The Ganciclovir Implant Study Group.

@article{Musch1997TreatmentOC,
  title={Treatment of cytomegalovirus retinitis with a sustained-release ganciclovir implant. The Ganciclovir Implant Study Group.},
  author={David C. Musch and Daniel F. Martin and J F G Gordon and Matthew D. Davis and Baruch D. Kuppermann},
  journal={The New England journal of medicine},
  year={1997},
  volume={337 2},
  pages={83-90}
}
BACKGROUND Sustained-release, intraocular implants that deliver ganciclovir are an alternative method for the treatment of cytomegalovirus retinitis in patients with the acquired immunodeficiency syndrome (AIDS). METHODS We conducted a randomized study of 188 patients with AIDS and newly diagnosed cytomegalovirus retinitis. The patients were randomly assigned to treatment with an implant delivering 1 microg of ganciclovir per hour, an implant delivering 2 microg of ganciclovir per hour, or… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 54 extracted citations

Complications after implantation of intraocular devices in patients with cytomegalovirus retinitis

Graefe's Archive for Clinical and Experimental Ophthalmology • 1999
View 4 Excerpts
Highly Influenced

Ocular pharmacology.

Journal of clinical pharmacology • 2016

Injectable formulations for an intravitreal sustained-release application of a novel single-chain VEGF antibody fragment.

European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V • 2015

Similar Papers

Loading similar papers…